Keratoconus: Clinical Trials

297 trials for Keratoconus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

132 completed, 78 unknown, 30 recruiting, 22 terminated. 114 Not applicable, 43 Phase 3, 40 Phase 2, 14 Phase 1, 6 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable114Completed 54, Unknown 32, Recruiting 10, Terminated 8, Not yet recruiting 5, Active not recruiting 3, Enrolling by invitation 1, Withdrawn 1
Phase 343Unknown 19, Completed 13, Terminated 5, Recruiting 4, Active not recruiting 1, Withdrawn 1
Phase 240Completed 14, Unknown 12, Terminated 5, Recruiting 4, Withdrawn 3, Enrolling by invitation 2
Phase 114Unknown 6, Completed 4, Enrolling by invitation 2, Recruiting 1, Withdrawn 1
Phase 46Completed 3, Not yet recruiting 1, Recruiting 1, Unknown 1
Early Phase 13Completed 1, Not yet recruiting 1, Unknown 1

Follow Keratoconus: new trials by email Literature Review of Keratoconus trials Research Report on Keratoconus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized Clinical Trial of Ex Vivo Corneal Cross-Linking of Donor Keratoplasty Tissue for Keratoconus Used for Keratoplasty in Keratoconus Patients
Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% with UV light, Riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% without UV light - Keratoconus
Not applicableNot yet recruitingJoseph B. Ciolino, MD2162027-01-012026-04-08
Performance Evaluation of the OCUTOP Hand-held Corneal Topographer
OCUTOP hand-held corneal topographer with OCUGRAPH software, Reference instrument measurement (corneal topography and tear-film assessment) - Corneal Topography, Dry Eye Syndromes
Not applicableNot yet recruitingUniversity of Plymouth1502027-01-012026-10-26
Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus
NOA lens type 1, NOA lens type 2 - Keratoconus, Presbyopia
Not applicableRecruitingAzalea Vision162026-09-282026-10-13
UNITY DX Cornea Study
UNITY DX, ANTERION - Tomography
RecruitingAlcon Research1102026-09-242026-10-27
Clinical and Subclinical Keratoconus Cohort Study
Keratoconus
Not yet recruitingZhongshan Ophthalmic Center, Sun Yat-sen University4212026-09-012026-04-28
A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases
Fuchs Endothelial Corneal Dysfunction, Open Angle Glaucoma (OAG)
RecruitingMassachusetts General Hospital902026-08-182026-08-25
Measuring the Changes of the Intraocular Pressure After Corneal Cross Linking Using Corvis CT
Corvis Machine - Keratoconus, Intraocular Pressure
Not applicableNot yet recruitingTanta University12026-07-102026-05-20
Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus
Riboflavin Ophthalmic Solutions, UV-A Irradiation System - Keratoconus
Phase 4RecruitingGlaukos Corporation152026-05-112026-06-05
Outcomes of CTAK Surgery
Questionnaire and Physical Exam - Keratoconus, Corneal Ectasia
Phase 4Not yet recruitingStanford University1002026-05-012026-04-24
Artificial Intelligence-assisted Diagnosis in Ophthalmology
No interventions - Macular Degeneration, Diabetic Retinopathy (DR)
Not yet recruitingMarisse Masis-Solano150002026-05-012026-04-01
Study of TN-001 Topical Eyedrops for Keratoconus
Low-dose TGF-B3 and Dexamethasone Sodium Phosphate, High-dose TGF-B3 and Dexamethasone Sodium Phosphate - Keratoconus
Phase 1 / Phase 2Enrolling by invitationTheiaNova Ltd.202025-12-232026-02-04
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
GLK-221 Ophthalmic Solution, Placebo Ophthalmic Solution - Keratoconus
Phase 2RecruitingGlaukos Corporation1002025-12-232026-02-10
INTACS (Intrastromal Corneal Ring Segments) For Corneal Ectasia
INTACS - Keratoconus
Not applicableNot yet recruitingUniversity of California, San Diego10002025-12-012024-05-07
Corneal Crosslinking for Treatment of Progressive Keratoconus or Corneal Ectasia
Riboflavin 0.1% ophthalmic solution and pulsed light, Riboflavin 0.1% ophthalmic solution and non-pulsed light - Keratoconus, Corneal Ectasia
Phase 2 / Phase 3RecruitingPrice Vision Group5002025-10-012026-09-25
PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus
Schwind AMARIS excimer laser, Corneal collagen crosslinking epi-off accelerated - Keratoconus
Not applicableRecruitingInstituto de Oftalmología Fundación Conde de Valenciana502025-09-012026-01-28
Keraring Implantation Based on Alfonso Nomogram
Intrastromal corneal ring segment implantation (ICRS) - Keratoconic Subjects
Not applicableCompletedAssiut University252025-09-012026-10-02
Electrophysiological Changes in Cases of Different Stages of Keratoconus
Keratoconus
Active not recruitingMinia University502025-08-202026-03-11
Effect of Corneal and Scleral RGP Lenses on Ocular Health and Visual Quality in Keratoconus
Rose K2, Onefit MED - Keratoconus, Irregular Astigmatism
Not applicableRecruitingUniversity of Aarhus502025-08-152025-08-24
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Epi-ON corneal cross-linking - Keratoconus, Ectasia of Cornea
Phase 3RecruitingWoolfson Eye Institute4852025-08-012026-02-02
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
Epi-ON corneal cross-linking (CXL) - Down Syndrome (DS), Keratoconus
Phase 3RecruitingWoolfson Eye Institute2252025-08-012026-02-02

Showing 20 of 297. Sign in to see all of them.

Narrower conditions

Corneal Diseases (36)  ·  Dilatation, Pathologic (23)  ·  Eye Diseases (10)  ·  Dry Eye Syndromes (9)  ·  Corneal Dystrophies, Hereditary (8)  ·  Glaucoma (7)  ·  Corneal Opacity (6)  ·  Fuchs' Endothelial Dystrophy (5)  ·  Astigmatism (4)  ·  Cataract (4)  ·  Corneal Injuries (4)  ·  Glaucoma, Open-Angle (3)  ·  Macular Degeneration (3)  ·  Corneal Wavefront Aberration (2)

Broader conditions

Eye Diseases (287)  ·  Corneal Diseases (261)  ·  Pathological Conditions, Signs and Symptoms (30)  ·  Pathological Conditions, Anatomical (23)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (16)  ·  Genetic Diseases, Inborn (15)  ·  Eye Diseases, Hereditary (14)  ·  Lacrimal Apparatus Diseases (9)  ·  Refractive Errors (7)  ·  Nervous System Diseases (6)  ·  Ocular Hypertension (6)  ·  Pathologic Processes (6)  ·  Corneal Dystrophies, Hereditary (5)  ·  Craniocerebral Trauma (4)  ·  Eye Injuries (4)

Interventions

Corneal Cross-Linking (31)  ·  Riboflavin (28)  ·  Tomography, Optical Coherence (7)  ·  Ophthalmic Solutions (5)  ·  Corneal Topography (4)  ·  prednisolone acetate (4)  ·  Calcium Dobesilate (3)  ·  Dextrans (3)  ·  Flavin Mononucleotide (3)  ·  Keratoplasty, Penetrating (3)  ·  Photorefractive Keratectomy (3)  ·  Surveys and Questionnaires (3)  ·  Drug Implants (2)  ·  Eyeglasses (2)  ·  Fluorometholone (2)

Sponsors

Assiut University (11)  ·  Cornea and Laser Eye Institute (10)  ·  Glaukos Corporation (8)  ·  Democritus University of Thrace (7)  ·  Oregon Health and Science University (6)  ·  Shahid Beheshti University of Medical Sciences (6)  ·  Cxlusa (5)  ·  Federal University of São Paulo (5)  ·  Medical University of Vienna (5)  ·  Zhongshan Ophthalmic Center, Sun Yat-sen University (5)  ·  Instituto de Oftalmología Fundación Conde de Valenciana (4)  ·  Moorfields Eye Hospital NHS Foundation Trust (4)  ·  Umeå University (4)  ·  University Hospital, Montpellier (4)  ·  Centre Hospitalier Régional Metz-Thionville (3)

Countries

United States (91)  ·  Egypt (22)  ·  France (22)  ·  Iran (13)  ·  United Kingdom (13)  ·  Brazil (12)  ·  China (12)  ·  Austria (10)  ·  Germany (8)  ·  Greece (6)  ·  Netherlands (6)  ·  Italy (5)  ·  Mexico (5)  ·  Spain (5)  ·  Switzerland (5)

Top investigators

Peter S Hersh, MD (5)  ·  Peter Hersh, MD (4)  ·  Aleksandar Stojanovic, MD (3)  ·  Mahmoud Abdel-Radi, MD (3)  ·  Steven A Greenstein, MD (3)  ·  William Trattler, MD (3)  ·  Yan Wang, Prof (3)  ·  Adimara C Renesto, MD (2)  ·  Bernard Delbosc, MD, PhD (2)  ·  David Huang, MD, PhD (2)  ·  Michael Belin, MD (2)  ·  Mukharram Bikbov, Professor (2)  ·  Parag Majmudar, MD (2)  ·  Peter Hersh, M.D. (2)  ·  Philip Maier, MD (2)

Results publications

PMID 12719068, PMID 16765803, PMID 16952090, PMID 17531694, PMID 18471635, PMID 20138607, PMID 24452012, PMID 25532633, PMID 32557558, PMID 33591032, PMID 41126474, PMID 10511934, PMID 10548467, PMID 10656302, PMID 10673340, PMID 10951465, PMID 10976937, PMID 11006081, PMID 11165859, PMID 11527942, PMID 11778801, PMID 11778802, PMID 11978762, PMID 12126755, PMID 12213147, PMID 14638698, PMID 14741001, PMID 14745032, PMID 15043821, PMID 15050269, PMID 15068441, PMID 15728537, PMID 16368147, PMID 16565005, PMID 16761238, PMID 16805116, PMID 16814056, PMID 16877401, PMID 16900027, PMID 16936089, PMID 17013692, PMID 17081868, PMID 17224118, PMID 17258522, PMID 17321396, PMID 17413959, PMID 17434435, PMID 17449031, PMID 17457183, PMID 17457184

NIH funding

R01EY018184 (2), R01EY028755 (2), 2015 (1), 2016 (1), 2018 (1), R01EY013178 (1), R01EY019055 (1), R01EY038655 (1)